F2G Plans Orphan Drug Strategy With Novel Antifungal

 
• By Joseph Haas
  
Superbug strain bacteria concept as a killer microbe shaped as a death skull face as a symbol for MRSA medical healthcare risk and antimicrobial health hazard as a 3D illustration on white. - Illustration
F2G thinks its novel antifungal can benefit patients who've run out of therapeutic options
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D